Remdesivir Market Size, Share & Growth Report 2032
Remdesivir Market By Dosage (2.5mg, 5mg, 100mg, 200mg), By Patient (Adult, Pediatric, And Geriatric), By Application (Ebola, SARS-COV, MERS-COV, COVID-19), By End User (Hospitals, Clinics, Pharmacy & Drug Stores, And Online Pharmacies), and By Region - Global Industry Perspective Comprehensive Analysis And Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 6.01 Billion | USD 11.12 Billion | 7.20% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Remdesivir Market, 2024 - 2032, (USD Billion)
- 2.2. Remdesivir Market: Snapshot
- Chapter 3. Global Remdesivir Market – Industry Analysis
- 3.1. Remdesivir Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Outbreaks of pandemics like COVID-19, Ebula
- 3.2.2. Growing prevalence of viral diseases
- 3.3. Restraints
- 3.3.1. High cost of Remdesivir
- 3.4. Opportunity
- 3.4.1. High investment in research and development to investigate for further uses of Remdesivir
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by Dosage segment
- 3.6.2. Market attractiveness analysis by Patient segment
- 3.6.3. Market attractiveness analysis by Application segment
- 3.6.4. Market attractiveness analysis by End user segment
- 3.6.5. Market attractiveness analysis by regional segment
- Chapter 4. Global Remdesivir Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Remdesivir market: company market share analysis, 2024
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Dosage type launches
- 4.2.3. Agreements, partnerships, cullaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Remdesivir Market – Dosage Type Segment Analysis
- 5.1. Global Remdesivir market overview: by Dosage type
- 5.1.1. Global Remdesivir market revenue share, by Dosage type, 2024 and 2032
- 5.2. 2.5mg
- 5.2.1. Global Remdesivir market by 2.5mg, 2024-2032 (USD Billion)
- 5.3. 5mg
- 5.3.1. Global Remdesivir market by 5mg, 2024-2032 (USD Billion)
- 5.4. 100mg
- 5.4.1. Global Remdesivir market by 100mg, 2024-2032 (USD Billion)
- 5.5. 200mg
- 5.5.1. Global Remdesivir market by 200mg, 2024-2032 (USD Billion)
- 5.1. Global Remdesivir market overview: by Dosage type
- Chapter 6. Global Remdesivir Market – Patient Segment Analysis
- 6.1. Global Remdesivir market overview: by Patient
- 6.1.1. Global Remdesivir market revenue share, by Patient, 2024 and 2032
- 6.2. Growth Factors
- 6.2.1. Global Remdesivir market by Growth Factors, 2024-2032 (USD Billion)
- 6.3. Adult
- 6.3.1. Global Remdesivir market by Adult, 2024-2032 (USD Billion)
- 6.4. Pediatric
- 6.4.1. Global Remdesivir market by Pediatric, 2024-2032 (USD Billion)
- 6.5. Geriatric
- 6.5.1. Global Remdesivir market by Geriatric, 2024-2032 (USD Billion)
- 6.1. Global Remdesivir market overview: by Patient
- Chapter 7. Global Remdesivir Market – Application Segment Analysis
- 7.1. Global Remdesivir market overview: by Application
- 7.1.1. Global Remdesivir market revenue share, by Application, 2024 and 2032
- 7.2. Growth Factors
- 7.2.1. Global Remdesivir market by Growth Factors, 2024-2032 (USD Billion)
- 7.3. Ebula
- 7.3.1. Global Remdesivir market by Ebula, 2024-2032 (USD Billion)
- 7.4. SARS-COV
- 7.4.1. Global Remdesivir market by SARS-COV, 2024-2032 (USD Billion)
- 7.5. MERS-COV
- 7.5.1. Global Remdesivir market by MERS-COV, 2024-2032 (USD Billion)
- 7.6. COVID-19
- 7.6.1. Global Remdesivir market by COVID-19, 2024-2032 (USD Billion)
- 7.1. Global Remdesivir market overview: by Application
- Chapter 8. Global Remdesivir Market – End user Segment Analysis
- 8.1. Global Remdesivir market overview: by End user
- 8.1.1. Global Remdesivir market revenue share, by End user, 2024 and 2032
- 8.2. Hospitals
- 8.2.1. Global Remdesivir market by Hospitals, 2024-2032 (USD Billion)
- 8.3. Clinics
- 8.3.1. Global Remdesivir market by Clinics, 2024-2032 (USD Billion)
- 8.4. Pharmacy & Drug Stores
- 8.4.1. Global Remdesivir market by Pharmacy & Drug Stores, 2024-2032 (USD Billion)
- 8.5. Online Pharmacies
- 8.5.1. Global Remdesivir market by Online Pharmacies, 2024-2032 (USD Billion)
- 8.1. Global Remdesivir market overview: by End user
- Chapter 9. Global Remdesivir Market - Regional Analysis
- 9.1. Global Remdesivir market overview: by region
- 9.1.1. Global Remdesivir market revenue share, by region, 2024 and 2032
- 9.2. North America
- 9.2.1. North America Remdesivir market, by country, 2024-2032 (USD Billion)
- 9.2.2. North America Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.2.3. North America Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.2.4. North America Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.2.5. North America Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.2.6. The U.S.
- 9.2.6.1. The U.S. Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.2.6.2. The U.S. Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.2.6.3. The U.S. Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.2.6.4. The U.S. Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.2.7. Rest of North America
- 9.2.7.1. Rest of North America Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.2.7.2. Rest of North America Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.2.7.3. Rest of North America Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.2.7.4. Rest of North America Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.3. Europe
- 9.3.1. Europe Remdesivir market, by country, 2024-2032 (USD Billion)
- 9.3.2. Europe Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.3.3. Europe Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.3.4. Europe Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.3.5. Europe Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.3.6. U.K.
- 9.3.6.1. U.K. Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.3.6.2. U.K. Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.3.6.3. U.K. Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.3.6.4. U.K. Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.3.6. U.K.
- 9.3.7. France
- 9.3.7.1. France Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.3.7.2. France Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.3.7.3. France Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.3.7.4. France Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.3.8. Germany
- 9.3.8.1. Germany Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.3.8.2. Germany Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.3.8.3. Germany Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.3.8.4. Germany Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.3.9. Rest of Europe
- 9.3.9.1. Rest of Europe Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.3.9.2. Rest of Europe Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.3.9.3. Rest of Europe Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.3.9.4. Rest of Europe Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific Remdesivir market, by country, 2024-2032 (USD Billion)
- 9.4.2. Asia Pacific Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.4.3. Asia Pacific Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.4.4. Asia Pacific Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.4.5. Asia Pacific Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.4.6. China
- 9.4.6.1. China Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.4.6.2. China Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.4.6.3. China Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.4.6.4. China Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.4.7. Japan
- 9.4.7.1. Japan Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.4.7.2. Japan Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.4.7.3. Japan Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.4.7.4. Japan Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.4.8. India
- 9.4.8.1. India Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.4.8.2. India Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.4.8.3. India Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.4.8.4. India Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.4.9. Rest of Asia Pacific
- 9.4.9.1. Rest of Asia Pacific Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.4.9.2. Rest of Asia Pacific Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.4.9.3. Rest of Asia Pacific Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.4.9.4. Rest of Asia Pacific Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.5. Latin America
- 9.5.1. Latin America Remdesivir market, by country, 2024-2032 (USD Billion)
- 9.5.2. Latin America Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.5.3. Latin America Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.5.4. Latin America Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.5.5. Latin America Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.5.6. Brazil
- 9.5.6.1. Brazil Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.5.6.2. Brazil Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.5.6.3. Brazil Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.5.6.4. Brazil Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.5.7. Rest of Latin America
- 9.5.7.1. Rest of Latin America Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.5.7.2. Rest of Latin America Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.5.7.3. Rest of Latin America Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.5.7.4. Rest of Latin America Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.6. Middle East & Africa
- 9.6.1. Middle East & Africa Remdesivir market, 2024-2032 (USD Billion)
- 9.6.2. Middle East & Africa Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
- 9.6.3. Middle East & Africa Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
- 9.6.4. Middle East & Africa Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
- 9.6.5. Middle East & Africa Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
- 9.1. Global Remdesivir market overview: by region
- Chapter 10. Company Profiles
- 10.1. Gilead Sciences.
- 10.1.1. Overview
- 10.1.2. Financials
- 10.1.3. Product Portfolio
- 10.1.4. Business Strategy
- 10.1.5. Recent Developments
- 10.2. Bright Gene
- 10.2.1. Overview
- 10.2.2. Financials
- 10.2.3. Product Portfolio
- 10.2.4. Business Strategy
- 10.2.5. Recent Developments
- 10.3. Hainan Haiyao.
- 10.3.1. Overview
- 10.3.2. Financials
- 10.3.3. Product Portfolio
- 10.3.4. Business Strategy
- 10.3.5. Recent Developments
- 10.4. Kelun Pharma
- 10.4.1. Overview
- 10.4.2. Financials
- 10.4.3. Product Portfolio
- 10.4.4. Business Strategy
- 10.4.5. Recent Developments
- 10.5. Hunan Warrant Pharmaceutical
- 10.5.1. Overview
- 10.5.2. Financials
- 10.5.3. Product Portfolio
- 10.5.4. Business Strategy
- 10.5.5. Recent Developments
- 10.6. Hetero
- 10.6.1. Overview
- 10.6.2. Financials
- 10.6.3. Product Portfolio
- 10.6.4. Business Strategy
- 10.6.5. Recent Developments
- 10.7. Cipla
- 10.7.1. Overview
- 10.7.2. Financials
- 10.7.3. Product Portfolio
- 10.7.4. Business Strategy
- 10.7.5. Recent Developments
- 10.8. Jubilant Lifesciences
- 10.8.1. Overview
- 10.8.2. Financials
- 10.8.3. Product Portfolio
- 10.8.4. Business Strategy
- 10.8.5. Recent Developments
- 10.1. Gilead Sciences.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Remdesivir market, 2024-2032 (USD Billion)
4. Porter’s five forces analysis: Remdesivir market
5. Global Remdesivir market attractiveness, by Dosage type
6. Global Remdesivir market attractiveness, by Patient
7. Global Remdesivir market attractiveness, by Application
8. Global Remdesivir market attractiveness, by End user
9. Global Remdesivir market attractiveness, by Region
10. Global Remdesivir market revenue share, by Dosage type, 2024 and 2032
11. Global Remdesivir market by 2.5mg, 2024-2032 (USD Billion)
12. Global Remdesivir market by 5mg, 2024-2032 (USD Billion)
13. Global Remdesivir market by 100mg, 2024-2032 (USD Billion)
14. Global Remdesivir market by 200mg, 2024-2032 (USD Billion)
15. Global Remdesivir market revenue share, by Patient, 2024 and 2032
16. Global Remdesivir market by Growth Factors, 2024-2032 (USD Billion)
17. Global Remdesivir market by Adult, 2024-2032 (USD Billion)
18. Global Remdesivir market by Pediatric, 2024-2032 (USD Billion)
19. Global Remdesivir market by Geriatric, 2024-2032 (USD Billion)
20. Global Remdesivir market revenue share, by Application, 2024 and 2032
21. Global Remdesivir market by Growth Factors, 2024-2032 (USD Billion)
22. Global Remdesivir market by Ebola, 2024-2032 (USD Billion)
23. Global Remdesivir market by SARS-COV, 2024-2032 (USD Billion)
24. Global Remdesivir market by MERS-COV, 2024-2032 (USD Billion)
25. Global Remdesivir market by COVID-19, 2024-2032 (USD Billion)
26. Global Remdesivir market revenue share, by End user, 2024 and 2032
27. Global Remdesivir market by Hospitals, 2024-2032 (USD Billion)
28. Global Remdesivir market by Clinics, 2024-2032 (USD Billion)
29. Global Remdesivir market by Pharmacy & Drug Stores, 2024-2032 (USD Billion)
30. Global Remdesivir market by Online Pharmacies, 2024-2032 (USD Billion)
31. Global Remdesivir market revenue share, by region, 2024 & 2025
32. North America Remdesivir market, 2024-2032 (USD Billion)
33. Europe Remdesivir market, 2024-2032 (USD Billion)
34. Asia Pacific Remdesivir market, 2024-2032 (USD Billion)
35. Latin America Remdesivir market, 2024-2032 (USD Billion)
36. Middle East & Africa Remdesivir market, 2024-2032 (USD Billion)
Table Of Tables
List of Tables
1. Global Remdesivir market: snapshot
2. Drivers for Remdesivir market: impact analysis
3. Restraints for Remdesivir market: impact analysis
4. North America Remdesivir market revenue, by country, 2024-2032 (USD Billion)
5. North America Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
6. North America Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
7. North America Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
8. North America Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
9. The U.S. Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
10. The U.S. Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
11. The U.S. Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
12. The U.S. Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
13. Rest of North America Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
14. Rest of North America Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
15. Rest of North America Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
16. Rest of North America Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
17. Europe Remdesivir market revenue, by country, 2024-2032 (USD Billion)
18. Europe Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
19. Europe Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
20. Europe Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
21. Europe Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
22. U.K. Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
23. U.K. Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
24. U.K. Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
25. U.K. Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
26. France Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
27. France Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
28. France Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
29. France Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
30. Germany Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
31. Germany Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
32. Germany Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
33. Germany Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
34. Rest of Europe Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
35. Rest of Europe Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
36. Rest of Europe Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
37. Rest of Europe Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
38. Asia Pacific Remdesivir market revenue, by country, 2024-2032 (USD Billion)
39. Asia Pacific Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
40. Asia Pacific Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
41. Asia Pacific Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
42. Asia Pacific Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
43. China Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
44. China Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
45. China Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
46. China Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
47. Japan Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
48. Japan Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
49. Japan Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
50. Japan Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
51. India Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
52. India Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
53. India Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
54. India Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
55. Rest of Asia Pacific Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
56. Rest of Asia Pacific Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
57. Rest of Asia Pacific Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
58. Rest of Asia Pacific Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
59. Latin America Remdesivir market revenue, by country, 2024-2032 (USD Billion)
60. Latin America Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
61. Latin America Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
62. Latin America Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
63. Latin America Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
64. Brazil Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
65. Brazil Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
66. Brazil Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
67. Brazil Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
68. Rest of Latin America Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
69. Rest of Latin America Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
70. Rest of Latin America Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
71. Rest of Latin America Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
72. Middle East & Africa Remdesivir market revenue, by Dosage type, 2024-2032 (USD Billion)
73. Middle East & Africa Remdesivir market revenue, by Patient, 2024-2032 (USD Billion)
74. Middle East & Africa Remdesivir market revenue, by Application, 2024-2032 (USD Billion)
75. Middle East & Africa Remdesivir market revenue, by End user, 2024-2032 (USD Billion)
Methodology
FrequentlyAsked Questions
Remdesivir is an antiviral medication used to treat some cases of COVID-19. It works by interfering with the virus's ability to copy itself inside human cells, slowing down its spread.
According to a study, the global remdesivir market size was worth around USD 6.01 billion in 2023 and is expected to reach USD 11.12 billion by 2032.
The global remdesivir market is expected to grow at a CAGR of 7.20% during the forecast period.
North America is expected to dominate the remdesivir market over the forecast period.
Leading players in the global remdesivir market include Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Hetero, Cipla, and Jubilant Lifesciences, among others.
The remdesivir market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
HappyClients
